Former Singapore Prime Minister Goh Chok Tong noted on social media that “Every day is a bonus,” despite suffering from radiation dermatitis from the treatment sessions that he finished last week.
Radiation dermatitis, or radiation rash or burns, is one of the most common side effects of cancer treatment radiotherapy.
It happens when the outer layers of a person’s skin is affected by radiation therapy.
About 95 per cent of those who undergo radiation therapy experience some form of dermatitis, such as redness, skin dryness, or skin peeling.
Most of these symptoms can be treated at home with skin creams applied onto affected areas for soothing effect.
The 79-year-old Mr Goh continue to live life positively, saying that he will get the Covid vaccine when his turn comes.
Goh Chok Tong is also looking forward to the release of the second part of his authorised biography, “Standing Tall.” His intention is to launch the book in late April or early May of this year, just in time for his 80th birthday.
The former Prime Minister also wrote that the book has been read by PM Lee Hsien Loong and another friend, who described it as “enjoyable.”
The first volume of his biography, ‘Tall Order: The Goh Chok Tong Story’, was released late in 2019 and covered his life until he became Singapore’s second Prime Minister in 1990.
The second volume is expected to cover the years of his premiership from 1990 to 2004.
Goh Chok Tong had a big shoe to fill in when he took over from the
legendary Lee Kuan Yew. Most didn’t expect him to do well especially when they
use Lee Kuan Yew as the benchmark. Goh Chok Tong would went on to prove his
critics wrong by leading Singapore for 14 years through recessions, terrorist
attacks, electoral setbacks and the epidemic of a virus.
新加坡前总理吴作栋最近在社交媒体上指出,“每天都要感恩”,尽管他上周结束癌症治疗过后皮肤敏感。
79岁的吴先生继续过着积极的生活,他补充说当轮到他时将愿意接种Covid疫苗。
吴作栋也期待发行他传记的第二部分“,,Standing Tall”。他的打算是在今年四月下旬或五月初,在他80岁生日时发行这本书。
前总理还写道,李显龙总理和另一位朋友已经读过这本书,他们形容这本书“很有趣”。
吴作栋从传奇的李光耀手中接棒时不被大多数人看好,尤其是他们将他与李光耀为做比较。吴作栋以成绩证明他的真正实力,他执政新加坡十四年,经济增长迅速成为亚洲四小虎之一。
No comments:
Post a Comment